ヨルダンの抗うつ薬の使用,支出,および人口統計学的処方パターンの傾向:遡及的分析
Safa' F Al Twahya1, Rima Hijazeen1, Hamzeh Almomani1
1Department of Biopharmaceutics and Clinical Pharmacy, University of Jordan, Amman, Jordan.
Expert review of pharmacoeconomics & outcomes research
|February 19, 2026
まとめ
ヨルダンの抗うつ薬の使用
科学分野:
- 薬学経済学 薬学経済学
- メンタルヘルス・サービス 研究 メンタルヘルス・サービス
- エピデミオロジー エピデミオロジー
背景:
- ヨルダンのパンデミック後のメンタルヘルスの需要は,COVID-19と地域的なストレス要因のために増加しています.
- 抗うつ剤の使用と費用を理解することは,効果的な治療へのアクセスとリソースの割り当てに不可欠です.
- この研究は,地域におけるメンタルヘルス支援の需要の増加に対応しています.
研究 の 目的:
- 2019年から2023年までのヨルダンの民間部門における抗うつ薬の利用と支出の動向を分析する.
- 患者の人口統計と臨床的徴候に基づいて処方パターンを調査する.
- メンタルヘルス政策と資源計画に関する情報提供.
主な方法:
- IQVIAの販売データ (2019-2023) を用いた遡及市場分析.
- 世界保健機関 (WHO) の定義日用量方法論を用いたデータの標準化.
- 人口統計および指標ベースのパターンのための処方データ (2021-2022) の分析.
主要な成果:
- 抗うつ薬の使用は2019年から2023年にかけて着実に増加し,セロトニン再吸収阻害剤 (SSRI) が優位 (79%) でした.
- エシタロプラムは最も多く処方されるSSRI (40%),次にセルトラリン (18.9%) でした.
- 処方箋は男性 (55.6%) と30歳から54歳までの成人の間でより一般的であり,主要な徴候 (46.7%) は重度のうつ病でした.
結論:
- セロトニン再吸収抑制剤,特にエシタロプラムは,ヨルダンの民間セクターで優勢です.
- 処方パターンは,年齢と性別によって異なり,異なる臨床的ニーズを示しています.
- 調査結果は,抗うつ薬の経済的負担が増加していることを強調しており,費用対効果の高い戦略と有意な精神保健介入が必要である.
さらに関連する動画
07:58Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression
Published on: February 24, 2023
1.0K
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
747
関連する概念動画
Prescription, Nonprescription and Orphan Drugs
1.5K
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.5K
Antidepressant Drugs: Overview
2.1K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
2.1K
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
2.3K
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
2.3K
Antidepressant Drugs: MAOIs and Other Agents
1.3K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.3K
Therapeutic Drug Monitoring: Affecting Factors
438
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
438
Drug Therapy
450
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
450
